LBA5CheckMate 214: Efficacy and safety of nivolumab +...

Annals of Oncology 2017 / 09 Vol. 28; Iss. suppl_5

LBA5CheckMate 214: Efficacy and safety of nivolumab + ipilimumab (N+I) v sunitinib (S) for treatment-naïve advanced or metastatic renal cell carcinoma (mRCC), including IMDC risk and PD-L1 expression subgroups

Escudier, B., Tannir, N.M., McDermott, D.F., Frontera, O.A., Melichar, B., Plimack, E.R., Barthelemy, P., George, S., Neiman, V., Porta, C., Choueiri, T.K., Powles, T., Donskov, F., Salman, P., Kollma
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx440.029
Date:
September, 2017
File:
PDF, 121 KB
english, 2017
Conversion to is in progress
Conversion to is failed